What is the recommended treatment for individuals with substance use disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Substance Use Disorders

The recommended treatment for individuals with substance use disorder includes a combination of pharmacotherapy and behavioral interventions tailored to the specific substance of abuse, with medication-assisted treatment being the gold standard for opioid use disorder and alcohol use disorder. 1

Initial Assessment and Screening

  • Use validated screening tools like the Drug Abuse Screening Test-10 (DAST-10) to identify substance misuse and categorize severity 1
  • Assess for comorbid psychiatric conditions, which are common in patients with SUDs 1
  • Screen for specific substance(s) of abuse to determine appropriate treatment approach 1

Substance-Specific Treatment Approaches

Opioid Use Disorder

  • First-line treatment: Medication-assisted treatment with opioid agonist therapy
    • Methadone maintenance treatment in conjunction with appropriate social and medical services 2
    • Buprenorphine as an alternative in outpatient settings 1
    • Naltrexone (380-mg monthly injection) for maintaining abstinence in motivated populations 3
  • Must be provided through certified Opioid Treatment Programs (OTPs) for outpatient maintenance 2

Alcohol Use Disorder

  • Pharmacotherapy options:
    • Acamprosate, disulfiram, or naltrexone to reduce relapse 3, 1
    • Selection based on patient preferences, motivation, and availability 3
  • Benzodiazepines as front-line medication for alcohol withdrawal management 3
  • Oral thiamine supplementation during withdrawal management 3

Stimulant Use Disorders (cocaine, methamphetamine)

  • No recommended pharmacologic treatment for stimulant dependence in primary care settings 3
  • Behavioral therapies have demonstrated effectiveness 3, 1
  • Brief interventions (5-30 minutes) incorporating individualized feedback 3, 1

Cannabis Use Disorder

  • Brief intervention with motivational interviewing techniques 3, 1
  • Short duration psychosocial support for treatment 3

Benzodiazepine Dependence

  • Planned withdrawal using gradually tapering doses over 8-12 weeks 3, 1
  • Convert to long-acting benzodiazepines rather than short-acting ones 3, 1

Behavioral Interventions

  • Psychosocial support should be routinely offered to all patients with SUDs 3, 1
  • Cognitive Behavioral Therapy (CBT) is effective for targeting cognitive, affective, and environmental risks 1
  • Contingency management is particularly effective for stimulant use disorders 1
  • Mutual help groups (e.g., Alcoholics Anonymous, Narcotics Anonymous) provide ongoing support 3
  • Family involvement in treatment when appropriate 3, 1

Treatment Settings and Referral Criteria

Outpatient Treatment

  • Appropriate for patients with relatively stable and safe living environments 3
  • Services include group and individual counseling and pharmacotherapy 3

Residential Treatment

  • Indicated for patients needing a stable and safe living environment 3, 1
  • Therapeutic community model for more intensive support 3

Indications for Specialist Referral

  • Failure to respond to brief interventions 3, 1
  • Need for medically supervised withdrawal 3
  • Comorbid chronic pain requiring opioid therapy 3
  • Co-occurring alcohol or benzodiazepine abuse 3
  • Uncontrolled or unstable psychiatric disorder 3, 1

Addressing Barriers and Special Considerations

  • Undertreatment is a significant concern, with only a small percentage of individuals receiving professional treatment 1
  • Integration of SUD treatment with primary care and mental health services improves outcomes 1
  • Address social determinants such as housing and employment 1
  • Implement harm reduction strategies including naloxone distribution and safe injection education 1
  • Telehealth options can improve access to treatment 1

Treatment Outcomes and Follow-up

  • Longer time in treatment and compliance with treatment plans are associated with lower risk of substance use 4
  • Addiction should be viewed as a chronic disorder with remissions and relapses like any other chronic disease 5
  • Treatment intensity should be adjusted according to the severity of the disorder 6
  • Continuous monitoring and follow-up are essential components of care 1

By implementing these evidence-based approaches and considering the specific needs of each patient with substance use disorder, healthcare providers can significantly improve outcomes and quality of life for these individuals.

References

Guideline

Substance Use Disorder Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.